# Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)

Study · id `cardio:ct-nct01007279` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01007279](<https://clinicaltrials.gov/study/NCT01007279>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01007279

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 160 participants.

## Technical summary

Registry record NCT01007279. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2010-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT01007279, source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01007279, source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)
- Primary completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01007279, source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)
- Completion: 2010-09 (actual) (ClinicalTrials.gov record NCT01007279, source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01007279, source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01007279-2010-10-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Rosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs)
- Acronym: ROMA
- Condition: Periprocedural Myocardial Necrosis
- Intervention (Drug): ROSUVASTATIN
- Lead sponsor: University of Roma La Sapienza
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: University of Roma La Sapienza (`cardio:org-university-of-roma-la-sapienza`)

## Provenance

Content hash: 51ba67ab995f20f3cc0a4bff815f1ed0498c025b727673c1454a9c8ad6913d26
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
